![Lucas Vitale](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lucas Vitale
Ufficiale delle Risorse Umane presso ORTHOFIX MEDICAL INC.
Patrimonio netto: 2 M $ in data 30/06/2024
Posizioni attive di Lucas Vitale
Società | Posizione | Inizio | Fine |
---|---|---|---|
ORTHOFIX MEDICAL INC. | Ufficiale delle Risorse Umane | 18/03/2024 | - |
Storia della carriera di Lucas Vitale
Precedenti posizioni note di Lucas Vitale
Società | Posizione | Inizio | Fine |
---|---|---|---|
Renagade Therapeutics, Inc.
![]() Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Ufficiale delle Risorse Umane | 01/10/2023 | 01/03/2024 |
BRUKER CELLULAR ANALYSIS, INC. | Ufficiale delle Risorse Umane | 01/04/2022 | 02/10/2023 |
NUVASIVE, INC. | Ufficiale delle Risorse Umane | 03/01/2019 | 17/09/2021 |
ARENA PHARMACEUTICALS | Ufficiale delle Risorse Umane | - | - |
Berkeley Lights, Inc.
![]() Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Ufficiale delle Risorse Umane | 13/04/2022 | - |
Formazione di Lucas Vitale
Hawaii Pacific University | Undergraduate Degree |
Alliant International University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Regno Unito | 2 |
Posizioni
Human Resources Officer | 6 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Technology Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ORTHOFIX MEDICAL INC. | Health Technology |
Aziende private | 5 |
---|---|
NuVasive, Inc.
![]() NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
Berkeley Lights, Inc.
![]() Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Technology Services |
Arena Pharmaceuticals, Inc.
![]() Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
PhenomeX, Inc.
![]() PhenomeX, Inc. Packaged SoftwareTechnology Services Bruker Cellular Analysis, Inc. is a biology company that engages in the study of cells. Its tools and services allow the prevention and treatment of disease. The company was founded in 2011 and is headquartered in Emeryville, CA. | Technology Services |
Renagade Therapeutics, Inc.
![]() Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Health Technology |
- Borsa valori
- Insiders
- Lucas Vitale
- Esperienza